115
Views
0
CrossRef citations to date
0
Altmetric
Bioanalytical Challenge

Discovery of A Novel Trimebutine Metabolite and its Impact on N-Desmethyltrimebutine Quantification by LC–MS/MS

, , , &
Pages 1007-1015 | Published online: 12 May 2015

References

  • Paquette J-M , RufiangeM, Iovu NiculitaMet al. Safety, tolerability and pharmacokinetics of trimebutine 3-thiocarbamoyl-benzenesulfonate (GIC-1001) in a randomized Phase I integrated design study: single & multiple ascending doses, effect of food, with healthy volunteers. Clinical Therapeutics36 (11), 1650–1664 (2014).
  • Centers for Disease Control and Prevention . US Department of Health and Human Services2014. http://www.cdc.gov/cancer/colorectal/index.htm.
  • Telford JJ , LevyAR, SambrookJCet al. The cost–effectiveness of screening for colorectal cancer. Can. Med. Assoc. J. 182, 1307–1313 (2010).
  • Seeff LC , RichardsTB, ShapiroJAet al. How many endoscopies are performed for colorectal cancer screening? Results from CDC’s survey of endoscopic capacity. Gastroenterology127, 1670–1677 (2004).
  • Cohen LB , DeleggeMH, AisenbergJet al. AGA Institute review of endoscopic sedation. Gastroenterology133 (2), 675–701 (2007).
  • Cohen LB , WecslerJS, GaetanoJNet al. Endoscopic sedation in the United States: results from a nationwide survey. Am. J. Gastroenterol. 101, 967–974 (2006).
  • Aljebreen AM , AlmadiMA, FelixWL. Sedated vs unsedated colonoscopy: A prospective study. World J. Gastroenterol. 20 (17), 5113–5118 (2014).
  • Triantafillidis JK , MerikasE, NikolakisDet al. Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol., 19 (4), 463–481 (2013).
  • Product Monograph Modulon® (trimebutine maleate) (2011). http://www.aptalispharma.com/pdf/modulon.pdf.
  • Guo W , ChengZU, ZhuYZ. Hydrogen sulfide and translational medicine. Acta Pharmacol. Sin. 34, 1284–1291 (2013).
  • Distrutti E , CiprianiS, RengaBet al. Hydrogen sulfide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. Mol. Pain. 6, 36 (2010).
  • Meunier JF , LauCK, GuayDet al. Novel sulfonate-based trimebutine salts PCT/CA2013/050178 (2013).
  • Roman FJ , LanetS, HamonJet al. Pharmacological properties of trimebutine and N-monodesmethyltrimebutine. J. Pharmacol. Exp. Ther. 289 (3), 1391–1397 (1999).
  • Jemal M , OuyangZ, XiaYQ. Systematic LC–MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed. Chromatogr. 24, 2–19 (2010).
  • Garofolo F , SavoieN, BergeronAet al. Importance of metabolite testing in regulated bioanalysis. Bioanalysis2 (7), 1171–1174 (2010).
  • Dicaire C , BérubéER, DumontIet al. Impact of oxcarbazepine sulfate metabolites on incurred sample reanalysis and quantification of oxcarbazepine. Bioanalysis3 (9), 973–982 (2011).
  • Shipkova M , SchutzE, ArmstrongVWet al. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. Clin. Chem. 46, 365–372 (2000).
  • Jemal M , XiaYQ. The need for adequate chromatographic separation in the quantitative determination of drugs in biological samples by high performance liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 13, 97–106 (1999).
  • Yan Z , CaldwellGW, JonesWJ, MasucciJA. Cone voltage induced in-source dissociation of glucuronides in electrospray and implications in biological analyses. Rapid Commun. Mass Spectrom. 17, 1433–1442 (2003).
  • An G , RuszajDM, MorrisME. Interference of a sulfate conjugate in quantitative liquid chromatography/tandem mass spectrometry through in-source dissociation. Rapid Commun. Mass Spectrom. 24, 1817–1819 (2010).
  • Savoie N , GarofoloF, Van AmterdamPet al. White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance. Bioanalysis2 (12), 1945–1960 (2010).
  • Garofolo F , RocciMLJr., DumontIet al. White Paper on Recent Issues in Regulated Bioanalysis and Regulatory Findings from Audits and Inspections. Bioanalysis3 (18), 2081–2096 (2011).
  • DeSilva B , GarofoloF, RocciMet al. White Paper on Recent Issues in Bioanalysis and Alignment on Multiple Guidelines. Bioanalysis4 (18), 2213–2226 (2012).
  • Stevenson L , GarofoloF, DeSilvaBet al. White Paper on Recent Issues in Bioanalysis: ‘Hybrid’ – the best of LBA and LCMS. Bioanalysis5 (23), 2903–2918 (2013).
  • Miura Y , ChishimaS, TakeyamaS. Studies of metabolic pathways of trimebutine by simultaneous administration of trimebutine and its deuterium-labeled metabolite. Drug Metabol. Dispos. 17 (4), 455–462 (1989).
  • Fast DM , KelleyM, ViswanathanCTet al. Workshop report and follow-up – AAPS workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples – implications of Crystal City Recommendations. AAPS J. 11 (2), 238–241 (2009).
  • US FDA, Guidance for Industry – Bioanalytical Method Validation (Draft Guidance), US FDA. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM368107.pdf.
  • EMA, Guideline on Bioanalytical Method Validation, EMA. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
  • Trontelj J . Quantification of glucuronide metabolites in biological matrices by LC–MS/MS. In : Tandem Mass Spectrometry – Applications and Principles. PrasainJK ( Ed), Intech, Croatia, 531–558 (2012). http://cdn.intechopen.com/pdfs-wm/29016.pdf.
  • Ciotti M , LakshmiVM, BasuNet al. Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides. Carcinogenesis20 (10), 1963–1969 (1999).
  • Kaivosaari S , FinelM, KoshinenM. N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases. Xenobiotica41 (8), 652–669 (2011).
  • Kemper RA , HayesJR, BogdanffyMS. Metabolism: a determinant of toxicology. In : Principles and Methods of Toxicology (5th Edition). Wallace HayesA ( Ed), CRC Press, New York, US, 136–142 (2008).
  • Wang H , ZhouH, HorimotoSet al. Quantitative determination of trimebutine maleate and its three metabolites in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B779, 173–187 (2002).
  • Jhee OH , LeeYS, ShawLMet al. Pharmacokinetic and bioequivalence evaluation of two formulations of 100 mg trimebutine maleate (Recutin™ and Polybutin™) in healthy male volunteers using the LC–MS/MS method. Clin. Chim. Acta375, 69–75 (2007).
  • Qin Y , ZhaoH, ZhangHet al. A novel gradient LC–MS/MS method for simultaneous determination of trimebutine maleate and its two metabolites in human plasma. Life Sci. J. 10 (1), 2840–2849 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.